A common asthma drug might accelerate the benefits of treatment for multiple sclerosis when combined with standard medicine, new research suggests.
The authors of this small and preliminary study showed that albuterol, prescribed for a variety of respiratory illnesses, enhances the effects of glatiramer acetate, a drug already prescribed for MS patients.
Because albuterol is known to reduce a substance in the body connected to the onset of MS, doctors at Harvard looked at using the drug as an add-on treatment.
Asthma drug could speed MS treatment
 | Increase Size |
   | |
| |
